<DOC>
	<DOCNO>NCT00569868</DOCNO>
	<brief_summary>To evaluate change coagulation ( blood clotting ) factor platelet function multiple myeloma participant undergo VELCADE treatment first time .</brief_summary>
	<brief_title>UARK 2005-05 , Coagulation-Related Effects Velcade Treatment Patients With Relapsed Refractory Multiple Myeloma</brief_title>
	<detailed_description>Cardiovascular complication treatment patient multiple myeloma uncommon , ( 10 % ) frequency clearly increase use regimen contain thalidomide combination glucocorticosteroids chemotherapy especially adriamycin . Even prophylactic anticoagulation , DVT still occur 10 % patient . The use full anticoagulation raise considerable concern bleed especially post chemotherapy thrombocytopenic period . We observe thromboembolic episode Velcade add thalidomide adriamycin contain chemotherapy . Therefore , would like investigate protective antithrombotic effect VELCADE malignancy associate hypercoagulable state group 10 patient Relapsed/Refractory Multiple Myeloma .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Patients myeloma relapsed one prior treatment demonstrate resistance last treatment , candidate receive Velcade normal PT PTT , evaluate inclusion present study . Previous history venous thromboembolism , myocardial infarction , stroke , TIA Hypercoagulable state ( deficit ATIII , Factor V Leiden , deficit protein S , deficit protein C , prothrombin gene mutation ) , antiphospholipid syndrome . Von Willebrand disease , inherited platelet abnormality . Familiar history hypercoagulable state . Anticoagulant therapy , aspirin , nonsteroidal antiinflammatory drug , beta blocker , tricyclic antidepressant , hormone replacement therapy , BCPs , agent able interfere platelet function previous two week . Nonsecretory MM , unless patient measurable lesion CT , MRI and/or PET .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>PLASMACYTOMA</keyword>
</DOC>